As previously announced, an exclusive distributor agreement has been signed with Prisma regarding marketing and sales of Calmark's COVID19-LDH test in Italy. This is now being expanded with the Neo products where the first to be launched is Neo-Bilirubin.
"It feels very good to get started with Neo-Bilirubin sales in Italy, where just over 400,000 children are born each year," says Magdalena Tharaldsen, Director International Business Development for Calmark. "I am also very happy to be able to extend the agreement with this distributor and I expect a quick sales start!"
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.